EVEREST ORGANICS share price has zoomed 11% and is presently trading at Rs 167.9.
Meanwhile, the BSE HEALTHCARE index is at 38,428.4 (down 0.4%).
Among the top gainers in the BSE HEALTHCARE index today are SUVEN PHARMACEUTICALS (up 4.5%) and ALEMBIC PHARMA (up 3.2%).
MAX HEALTHCARE INSTITUTE (down 1.6%) and AJANTA PHARMA (down 1.5%) are among the top losers today.
Over the last one year, EVEREST ORGANICS has moved up from Rs 123.4 to Rs 167.9, registering a gain of Rs 44.5 (up 36.1%).
On the other hand, the BSE HEALTHCARE index has moved up from 25,922.2 to 38,428.4, registering a gain of 48.2% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Glenmark Pharma (up 107.0%), Lupin (up 101.6%) and Cadila Healthcare (up 100.0%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 79,801.5 (down 0.2%).
The top losers among the BSE Sensex today are Nestle (down 1.8%) and Bajaj Finance (down 1.5%). The most traded stocks in the BSE Sensex are Tata Steel and Power Grid Corp..
In the meantime, NSE Nifty is at 24,292.4 (down 0.1%). Nestle and Bajaj Auto are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 65,344.2 to 79,801.5, registering a gain of 14,457.3 points (up 22.1%).
EVEREST ORGANICS net profit fell 48.7% YoY to Rs 1 million for the quarter ended March 2024, compared to a profit of Rs 1 million a year ago. Net sales rose 3.7% to Rs 526 million during the period as against Rs 508 million in January-March 2023.
For the year ended March 2023, EVEREST ORGANICS reported 115.9% decrease in net profit to Rs -2 million compared to net profit of Rs 11 million during FY22. Revenue of the company fell 7.4% to Rs 1,574 million during FY23.
The current Price to earnings ratio of EVEREST ORGANICS, based on rolling 12 month earnings, stands at 966.6.
Equitymaster requests your view! Post a comment on "EVEREST ORGANICS Gains 11%; BSE HEALTHCARE Index Down 0.4%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!